Two glioblastoma patients treated with Temferon have lived 3 years post-surgery; one had no progression, the other stabilized ...

Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World ...

Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care ...

Waldenström macroglobulinemia is often slow growing, with a 78% five-year survival rate, but chronic conditions can affect ...

Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...

Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.